INGEVITY CORP (NGVT) Fundamental Analysis & Valuation

NYSE:NGVT • US45688C1071

64.95 USD
-2.24 (-3.33%)
At close: Mar 6, 2026
64.95 USD
0 (0%)
After Hours: 3/6/2026, 7:38:29 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This NGVT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall NGVT gets a fundamental rating of 4 out of 10. We evaluated NGVT against 83 industry peers in the Chemicals industry. NGVT has a medium profitability rating, but doesn't score so well on its financial health evaluation. NGVT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. NGVT Profitability Analysis

1.1 Basic Checks

  • In the past year NGVT was profitable.
  • In the past year NGVT had a positive cash flow from operations.
  • In multiple years NGVT reported negative net income over the last 5 years.
  • NGVT had a positive operating cash flow in 4 of the past 5 years.
NGVT Yearly Net Income VS EBIT VS OCF VS FCFNGVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

  • NGVT has a worse Return On Assets (-3.59%) than 63.86% of its industry peers.
  • NGVT has a Return On Equity of -47.72%. This is amonst the worse of the industry: NGVT underperforms 81.93% of its industry peers.
  • NGVT has a better Return On Invested Capital (16.21%) than 98.80% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for NGVT is above the industry average of 6.36%.
  • The last Return On Invested Capital (16.21%) for NGVT is above the 3 year average (10.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -3.59%
ROE -47.72%
ROIC 16.21%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
NGVT Yearly ROA, ROE, ROICNGVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • NGVT has a Operating Margin of 22.78%. This is amongst the best in the industry. NGVT outperforms 91.57% of its industry peers.
  • In the last couple of years the Operating Margin of NGVT has declined.
  • NGVT has a Gross Margin of 38.02%. This is in the better half of the industry: NGVT outperforms 78.31% of its industry peers.
  • In the last couple of years the Gross Margin of NGVT has declined.
Industry RankSector Rank
OM 22.78%
PM (TTM) N/A
GM 38.03%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
NGVT Yearly Profit, Operating, Gross MarginsNGVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. NGVT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NGVT is creating some value.
  • There is no outstanding debt for NGVT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NGVT Yearly Shares OutstandingNGVT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NGVT Yearly Total Debt VS Total AssetsNGVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • NGVT has an Altman-Z score of 2.51. This is not the best score and indicates that NGVT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • NGVT has a better Altman-Z score (2.51) than 71.08% of its industry peers.
  • NGVT has a debt to FCF ratio of 5.26. This is a neutral value as NGVT would need 5.26 years to pay back of all of its debts.
  • NGVT has a better Debt to FCF ratio (5.26) than 78.31% of its industry peers.
  • A Debt/Equity ratio of 8.39 is on the high side and indicates that NGVT has dependencies on debt financing.
  • With a Debt to Equity ratio value of 8.39, NGVT is not doing good in the industry: 92.77% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 8.39
Debt/FCF 5.26
Altman-Z 2.51
ROIC/WACC1.41
WACC11.49%
NGVT Yearly LT Debt VS Equity VS FCFNGVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that NGVT should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.27, NGVT is doing worse than 85.54% of the companies in the same industry.
  • NGVT has a Quick Ratio of 1.27. This is a bad value and indicates that NGVT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NGVT has a worse Quick ratio (0.80) than 79.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.8
NGVT Yearly Current Assets VS Current LiabilitesNGVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NGVT Growth Analysis

3.1 Past

  • NGVT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.54%, which is quite impressive.
  • The Earnings Per Share has been decreasing by -1.44% on average over the past years.
EPS 1Y (TTM)26.54%
EPS 3Y-8.99%
EPS 5Y-1.44%
EPS Q2Q%-33.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-14.63%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.02% on average over the next years. This is quite good.
  • Based on estimates for the next years, NGVT will show a decrease in Revenue. The Revenue will decrease by -1.19% on average per year.
EPS Next Y11.51%
EPS Next 2Y16.04%
EPS Next 3Y14.02%
EPS Next 5YN/A
Revenue Next Year-4.55%
Revenue Next 2Y-2.26%
Revenue Next 3Y-1.19%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
NGVT Yearly Revenue VS EstimatesNGVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
NGVT Yearly EPS VS EstimatesNGVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. NGVT Valuation Analysis

4.1 Price/Earnings Ratio

  • NGVT is valuated correctly with a Price/Earnings ratio of 14.34.
  • NGVT's Price/Earnings ratio is a bit cheaper when compared to the industry. NGVT is cheaper than 72.29% of the companies in the same industry.
  • NGVT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.29.
  • Based on the Price/Forward Earnings ratio of 12.86, the valuation of NGVT can be described as correct.
  • Based on the Price/Forward Earnings ratio, NGVT is valued a bit cheaper than the industry average as 72.29% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 24.57. NGVT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.34
Fwd PE 12.86
NGVT Price Earnings VS Forward Price EarningsNGVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 69.88% of the companies in the same industry are more expensive than NGVT, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NGVT indicates a rather cheap valuation: NGVT is cheaper than 89.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.57
EV/EBITDA 8.97
NGVT Per share dataNGVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as NGVT's earnings are expected to grow with 14.02% in the coming years.
PEG (NY)1.25
PEG (5Y)N/A
EPS Next 2Y16.04%
EPS Next 3Y14.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NGVT Dividend Analysis

5.1 Amount

  • No dividends for NGVT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NGVT Fundamentals: All Metrics, Ratios and Statistics

INGEVITY CORP

NYSE:NGVT (3/6/2026, 7:38:29 PM)

After market: 64.95 0 (0%)

64.95

-2.24 (-3.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-25
Earnings (Next)05-04
Inst Owners104.29%
Inst Owner Change2.09%
Ins Owners0.97%
Ins Owner Change-0.54%
Market Cap2.29B
Revenue(TTM)N/A
Net Income(TTM)-65.90M
Analysts82
Price Target72.17 (11.12%)
Short Float %3.79%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.22%
Min EPS beat(2)7.21%
Max EPS beat(2)17.23%
EPS beat(4)4
Avg EPS beat(4)64.73%
Min EPS beat(4)7.21%
Max EPS beat(4)202.89%
EPS beat(8)7
Avg EPS beat(8)67.55%
EPS beat(12)8
Avg EPS beat(12)41.47%
EPS beat(16)11
Avg EPS beat(16)35.94%
Revenue beat(2)0
Avg Revenue beat(2)-7.44%
Min Revenue beat(2)-9.4%
Max Revenue beat(2)-5.48%
Revenue beat(4)0
Avg Revenue beat(4)-5.77%
Min Revenue beat(4)-9.4%
Max Revenue beat(4)-2.47%
Revenue beat(8)2
Avg Revenue beat(8)-2.35%
Revenue beat(12)2
Avg Revenue beat(12)-3.18%
Revenue beat(16)6
Avg Revenue beat(16)-0.14%
PT rev (1m)1.8%
PT rev (3m)6.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.7%
EPS NY rev (1m)0%
EPS NY rev (3m)3.18%
Revenue NQ rev (1m)-3.62%
Revenue NQ rev (3m)-5.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.08%
Valuation
Industry RankSector Rank
PE 14.34
Fwd PE 12.86
P/S 1.79
P/FCF 9.57
P/OCF 7.68
P/B 16.6
P/tB N/A
EV/EBITDA 8.97
EPS(TTM)4.53
EY6.97%
EPS(NY)5.05
Fwd EY7.78%
FCF(TTM)6.79
FCFY10.45%
OCF(TTM)8.46
OCFY13.03%
SpS36.3
BVpS3.91
TBVpS-3.79
PEG (NY)1.25
PEG (5Y)N/A
Graham Number19.97
Profitability
Industry RankSector Rank
ROA -3.59%
ROE -47.72%
ROCE 20.52%
ROIC 16.21%
ROICexc 17.22%
ROICexgc 21.61%
OM 22.78%
PM (TTM) N/A
GM 38.03%
FCFM 18.7%
ROA(3y)-4.58%
ROA(5y)-0.24%
ROE(3y)-63.66%
ROE(5y)-29.04%
ROIC(3y)10.65%
ROIC(5y)10.84%
ROICexc(3y)11.07%
ROICexc(5y)11.72%
ROICexgc(3y)17.77%
ROICexgc(5y)19.74%
ROCE(3y)13.49%
ROCE(5y)13.72%
ROICexgc growth 3Y-8.19%
ROICexgc growth 5Y-5.86%
ROICexc growth 3Y-1.67%
ROICexc growth 5Y-0.8%
OM growth 3Y-6.17%
OM growth 5Y-4.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.27%
GM growth 5Y-2.81%
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 8.39
Debt/FCF 5.26
Debt/EBITDA 2.93
Cap/Depr 56.89%
Cap/Sales 4.61%
Interest Coverage 3.89
Cash Conversion 75.5%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 0.8
Altman-Z 2.51
F-Score7
WACC11.49%
ROIC/WACC1.41
Cap/Depr(3y)97.35%
Cap/Depr(5y)93.69%
Cap/Sales(3y)6.85%
Cap/Sales(5y)6.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.54%
EPS 3Y-8.99%
EPS 5Y-1.44%
EPS Q2Q%-33.68%
EPS Next Y11.51%
EPS Next 2Y16.04%
EPS Next 3Y14.02%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-14.63%
Revenue Next Year-4.55%
Revenue Next 2Y-2.26%
Revenue Next 3Y-1.19%
Revenue Next 5YN/A
EBIT growth 1Y35.28%
EBIT growth 3Y-5.83%
EBIT growth 5Y-2.78%
EBIT Next Year59.26%
EBIT Next 3Y18.42%
EBIT Next 5Y14.42%
FCF growth 1Y85.88%
FCF growth 3Y-35.4%
FCF growth 5Y-20.53%
OCF growth 1Y15.42%
OCF growth 3Y-24%
OCF growth 5Y-14.15%

INGEVITY CORP / NGVT FAQ

What is the ChartMill fundamental rating of INGEVITY CORP (NGVT) stock?

ChartMill assigns a fundamental rating of 4 / 10 to NGVT.


What is the valuation status for NGVT stock?

ChartMill assigns a valuation rating of 6 / 10 to INGEVITY CORP (NGVT). This can be considered as Fairly Valued.


Can you provide the profitability details for INGEVITY CORP?

INGEVITY CORP (NGVT) has a profitability rating of 4 / 10.


How financially healthy is INGEVITY CORP?

The financial health rating of INGEVITY CORP (NGVT) is 3 / 10.